1
|
Deacetylase inhibition promotes the generation and function of regulatory T cells.
|
Nat Med
|
2007
|
6.61
|
2
|
Messenger RNA for FOXP3 in the urine of renal-allograft recipients.
|
N Engl J Med
|
2005
|
5.02
|
3
|
Homeostatic proliferation is a barrier to transplantation tolerance.
|
Nat Med
|
2003
|
4.12
|
4
|
FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression.
|
Proc Natl Acad Sci U S A
|
2007
|
3.32
|
5
|
Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor.
|
J Exp Med
|
2005
|
3.17
|
6
|
Helios expression is a marker of T cell activation and proliferation.
|
PLoS One
|
2011
|
2.55
|
7
|
TRAF6 is a critical factor for dendritic cell maturation and development.
|
Immunity
|
2003
|
2.36
|
8
|
Immunomodulatory effects of deacetylase inhibitors: therapeutic targeting of FOXP3+ regulatory T cells.
|
Nat Rev Drug Discov
|
2009
|
2.00
|
9
|
PTEN inhibits IL-2 receptor-mediated expansion of CD4+ CD25+ Tregs.
|
J Clin Invest
|
2006
|
1.93
|
10
|
Transcriptional regulation by Foxp3 is associated with direct promoter occupancy and modulation of histone acetylation.
|
J Biol Chem
|
2006
|
1.84
|
11
|
Histone deacetylase 6 and heat shock protein 90 control the functions of Foxp3(+) T-regulatory cells.
|
Mol Cell Biol
|
2011
|
1.82
|
12
|
Inhibition of HDAC9 increases T regulatory cell function and prevents colitis in mice.
|
Gastroenterology
|
2009
|
1.81
|
13
|
Reduced cytotoxic function of effector CD8+ T cells is responsible for indoleamine 2,3-dioxygenase-dependent immune suppression.
|
J Immunol
|
2009
|
1.72
|
14
|
Histone deacetylases 6 and 9 and sirtuin-1 control Foxp3+ regulatory T cell function through shared and isoform-specific mechanisms.
|
Sci Signal
|
2012
|
1.71
|
15
|
Programmed death-1 targeting can promote allograft survival.
|
J Immunol
|
2002
|
1.68
|
16
|
Primary coenzyme Q deficiency in Pdss2 mutant mice causes isolated renal disease.
|
PLoS Genet
|
2008
|
1.66
|
17
|
TGF-beta and IL-6 signals modulate chromatin binding and promoter occupancy by acetylated FOXP3.
|
Proc Natl Acad Sci U S A
|
2008
|
1.65
|
18
|
Differential effects of B and T lymphocyte attenuator and programmed death-1 on acceptance of partially versus fully MHC-mismatched cardiac allografts.
|
J Immunol
|
2005
|
1.55
|
19
|
Sirtuin-1 targeting promotes Foxp3+ T-regulatory cell function and prolongs allograft survival.
|
Mol Cell Biol
|
2011
|
1.53
|
20
|
BTLA targeting modulates lymphocyte phenotype, function, and numbers and attenuates disease in nonobese diabetic mice.
|
J Leukoc Biol
|
2009
|
1.53
|
21
|
Improved renal ischemia tolerance in females influences kidney transplantation outcomes.
|
J Clin Invest
|
2016
|
1.51
|
22
|
Genetic variation in the prostaglandin E2 pathway is associated with primary graft dysfunction.
|
Am J Respir Crit Care Med
|
2014
|
1.51
|
23
|
Accelerated memory cell homeostasis during T cell depletion and approaches to overcome it.
|
J Immunol
|
2006
|
1.51
|
24
|
Noninvasive detection of renal allograft inflammation by measurements of mRNA for IP-10 and CXCR3 in urine.
|
Kidney Int
|
2004
|
1.48
|
25
|
Safety and efficacy of a calcineurin inhibitor avoidance regimen in pediatric renal transplantation.
|
J Am Soc Nephrol
|
2006
|
1.45
|
26
|
BAFF binding to T cell-expressed BAFF-R costimulates T cell proliferation and alloresponses.
|
Eur J Immunol
|
2004
|
1.44
|
27
|
Mechanisms underlying blockade of allograft acceptance by TLR ligands.
|
J Immunol
|
2008
|
1.41
|
28
|
Nasal vaccination with myelin oligodendrocyte glycoprotein reduces stroke size by inducing IL-10-producing CD4+ T cells.
|
J Immunol
|
2003
|
1.40
|
29
|
Delayed and deficient dermal maturation in mice lacking the CXCR3 ELR-negative CXC chemokine receptor.
|
Am J Pathol
|
2007
|
1.38
|
30
|
Targeting IL-15 receptor-bearing cells with an antagonist mutant IL-15/Fc protein prevents disease development and progression in murine collagen-induced arthritis.
|
J Immunol
|
2004
|
1.33
|
31
|
Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer.
|
J Clin Invest
|
2014
|
1.33
|
32
|
B7-H3 promotes acute and chronic allograft rejection.
|
Eur J Immunol
|
2005
|
1.31
|
33
|
Histone/protein deacetylase inhibitors increase suppressive functions of human FOXP3+ Tregs.
|
Clin Immunol
|
2010
|
1.30
|
34
|
Mutant prenyltransferase-like mitochondrial protein (PLMP) and mitochondrial abnormalities in kd/kd mice.
|
Kidney Int
|
2004
|
1.24
|
35
|
Histone acetyltransferase mediated regulation of FOXP3 acetylation and Treg function.
|
Curr Opin Immunol
|
2010
|
1.23
|
36
|
Deacetylase inhibition increases regulatory T cell function and decreases incidence and severity of collagen-induced arthritis.
|
Exp Mol Pathol
|
2009
|
1.22
|
37
|
Prolongation of cardiac and islet allograft survival by a blocking hamster anti-mouse CXCR3 monoclonal antibody.
|
Transplantation
|
2008
|
1.22
|
38
|
Allograft rejection in a new allospecific CD4+ TCR transgenic mouse.
|
Am J Transplant
|
2003
|
1.21
|
39
|
Using histone deacetylase inhibitors to enhance Foxp3(+) regulatory T-cell function and induce allograft tolerance.
|
Immunol Cell Biol
|
2009
|
1.20
|
40
|
Histone/protein deacetylases control Foxp3 expression and the heat shock response of T-regulatory cells.
|
Curr Opin Immunol
|
2011
|
1.17
|
41
|
Regulatory T cell expression of herpesvirus entry mediator suppresses the function of B and T lymphocyte attenuator-positive effector T cells.
|
J Immunol
|
2008
|
1.15
|
42
|
Blocking the monocyte chemoattractant protein-1/CCR2 chemokine pathway induces permanent survival of islet allografts through a programmed death-1 ligand-1-dependent mechanism.
|
J Immunol
|
2003
|
1.15
|
43
|
Histone/protein deacetylases and T-cell immune responses.
|
Blood
|
2012
|
1.14
|
44
|
Structural and biological features of FOXP3 dimerization relevant to regulatory T cell function.
|
Cell Rep
|
2012
|
1.14
|
45
|
Systemic transforming growth factor-beta1 gene therapy induces Foxp3+ regulatory cells, restores self-tolerance, and facilitates regeneration of beta cell function in overtly diabetic nonobese diabetic mice.
|
Transplantation
|
2005
|
1.13
|
46
|
Selective targeting of the LIGHT-HVEM costimulatory system for the treatment of graft-versus-host disease.
|
Blood
|
2006
|
1.12
|
47
|
Systemic rather than local heme oxygenase-1 overexpression improves cardiac allograft outcomes in a new transgenic mouse.
|
J Immunol
|
2003
|
1.12
|
48
|
Modulation of LIGHT-HVEM costimulation prolongs cardiac allograft survival.
|
J Exp Med
|
2002
|
1.10
|
49
|
Programmed cell death 1 (PD-1) and its ligand PD-L1 are required for allograft tolerance.
|
Eur J Immunol
|
2007
|
1.10
|
50
|
Substrate rigidity regulates human T cell activation and proliferation.
|
J Immunol
|
2012
|
1.09
|
51
|
Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse.
|
Diabetes
|
2006
|
1.05
|
52
|
TNF receptor-associated factor 6 deficiency during hemopoiesis induces Th2-polarized inflammatory disease.
|
J Immunol
|
2003
|
1.03
|
53
|
Inhibition of p300 impairs Foxp3⁺ T regulatory cell function and promotes antitumor immunity.
|
Nat Med
|
2013
|
1.02
|
54
|
The mitochondrial and kidney disease phenotypes of kd/kd mice under germfree conditions.
|
J Autoimmun
|
2005
|
1.01
|
55
|
Multiple combination therapies involving blockade of ICOS/B7RP-1 costimulation facilitate long-term islet allograft survival.
|
Am J Transplant
|
2004
|
1.00
|
56
|
Differential expression of profibrotic and growth factors in chronic allograft nephropathy.
|
Transplantation
|
2006
|
0.99
|
57
|
Two lysines in the forkhead domain of foxp3 are key to T regulatory cell function.
|
PLoS One
|
2012
|
0.97
|
58
|
Foxp3 processing by proprotein convertases and control of regulatory T cell function.
|
J Biol Chem
|
2008
|
0.97
|
59
|
CXCR3+CD4+ T cells mediate innate immune function in the pathophysiology of liver ischemia/reperfusion injury.
|
J Immunol
|
2006
|
0.97
|
60
|
Biochemistry and therapeutic implications of mechanisms involved in FOXP3 activity in immune suppression.
|
Curr Opin Immunol
|
2007
|
0.94
|
61
|
Serum cytokine profiles associated with early allograft dysfunction in patients undergoing liver transplantation.
|
Liver Transpl
|
2012
|
0.93
|
62
|
Mbd2 promotes foxp3 demethylation and T-regulatory-cell function.
|
Mol Cell Biol
|
2013
|
0.92
|
63
|
Coinhibitory T-cell signaling in islet allograft rejection and tolerance.
|
Cell Transplant
|
2006
|
0.92
|
64
|
Foxp3+ T-regulatory cells require DNA methyltransferase 1 expression to prevent development of lethal autoimmunity.
|
Blood
|
2013
|
0.92
|
65
|
The cyclin-dependent kinase inhibitor p27kip1 is required for transplantation tolerance induced by costimulatory blockade.
|
J Immunol
|
2006
|
0.91
|
66
|
Second-generation histone deacetylase 6 inhibitors enhance the immunosuppressive effects of Foxp3+ T-regulatory cells.
|
J Med Chem
|
2012
|
0.91
|
67
|
Glomerular and tubular epithelial defects in kd/kd mice lead to progressive renal failure.
|
Am J Nephrol
|
2005
|
0.91
|
68
|
Proapoptotic Bax is hyperexpressed in isolated human islets compared with antiapoptotic Bcl-2.
|
Transplantation
|
2002
|
0.90
|
69
|
Enforced c-REL deficiency prolongs survival of islet allografts1.
|
Transplantation
|
2002
|
0.89
|
70
|
FOXP3+ regulatory T cell development and function require histone/protein deacetylase 3.
|
J Clin Invest
|
2015
|
0.89
|
71
|
Permanent survival of fully MHC-mismatched islet allografts by targeting a single chemokine receptor pathway.
|
J Immunol
|
2005
|
0.89
|
72
|
Resistance of Foxp3+ regulatory T cells to Nur77-induced apoptosis promotes allograft survival.
|
PLoS One
|
2008
|
0.89
|
73
|
Chemokines and transplant immunobiology.
|
J Am Soc Nephrol
|
2002
|
0.89
|
74
|
Pirfenidone inhibits T-cell activation, proliferation, cytokine and chemokine production, and host alloresponses.
|
Transplantation
|
2009
|
0.87
|
75
|
Regulating regulatory T cells to achieve transplant tolerance.
|
Hepatobiliary Pancreat Dis Int
|
2007
|
0.87
|
76
|
Histone deacetylase inhibitors and transplantation.
|
Curr Opin Immunol
|
2007
|
0.87
|
77
|
Cyclin-dependent kinase 2 controls peripheral immune tolerance.
|
J Immunol
|
2012
|
0.86
|
78
|
Herpesvirus entry mediator regulates hypoxia-inducible factor-1α and erythropoiesis in mice.
|
J Clin Invest
|
2011
|
0.85
|
79
|
Normalization of brain death-induced injury to rat renal allografts by recombinant soluble P-selectin glycoprotein ligand.
|
J Am Soc Nephrol
|
2002
|
0.85
|
80
|
Cyclophosphamide modulates CD4+ T cells into a T helper type 2 phenotype and reverses increased IFN-gamma production of CD8+ T cells in secondary progressive multiple sclerosis.
|
J Neuroimmunol
|
2004
|
0.83
|
81
|
Anti-CD28 monoclonal antibody therapy prevents chronic rejection of renal allografts in rats.
|
J Am Soc Nephrol
|
2002
|
0.83
|
82
|
Negative and positive co-signaling with anti-BTLA (PJ196) and CTLA4Ig prolongs islet allograft survival.
|
Transplantation
|
2007
|
0.81
|
83
|
Viral IL-10 gene transfer inhibits the expression of multiple chemokine and chemokine receptor genes induced by inflammatory or adaptive immune stimuli.
|
Am J Transplant
|
2003
|
0.80
|
84
|
Selectin inhibitor bimosiamose prolongs survival of kidney allografts by reduction in intragraft production of cytokines and chemokines.
|
J Am Soc Nephrol
|
2004
|
0.80
|
85
|
Indoleamine 2,3-dioxygenase and metabolites protect murine lung allografts and impair the calcium mobilization of T cells.
|
Am J Respir Cell Mol Biol
|
2012
|
0.79
|
86
|
Regulatory allospecific T cell clones abrogate chronic allograft rejection.
|
J Am Soc Nephrol
|
2009
|
0.78
|
87
|
Combination of isoform-selective histone/protein deacetylase inhibitors improves Foxp3+ T-regulatory cell function.
|
Cell Cycle
|
2012
|
0.78
|
88
|
Selectin blockade plus therapy with low-dose sirolimus and cyclosporin a prevent brain death-induced renal allograft dysfunction.
|
Am J Transplant
|
2005
|
0.78
|
89
|
Donor hypertension increases graft immunogenicity and intensifies chronic changes in long-surviving renal allografts.
|
Transplantation
|
2004
|
0.78
|
90
|
Early and late injury to renal transplants from non-heart-beating donors.
|
Transplantation
|
2002
|
0.77
|
91
|
Recipient hypertension potentiates chronic functional and structural injury of rat renal allografts.
|
Transplantation
|
2002
|
0.77
|
92
|
Inhibitory effects of pirfenidone on dendritic cells and lung allograft rejection.
|
Transplantation
|
2012
|
0.77
|
93
|
Allograft rejection requires STAT5a/b-regulated antiapoptotic activity in T cells but not B cells.
|
J Immunol
|
2006
|
0.77
|
94
|
Heat shock protein 70 is required for optimal liver regeneration after partial hepatectomy in mice.
|
Liver Transpl
|
2014
|
0.76
|
95
|
Strategies to cure experimental autoimmune colitis using antigen-specific Foxp3+ regulatory T cells.
|
Gastroenterology
|
2008
|
0.76
|
96
|
FOXP3⁺ regulatory T cell development and function require histone/protein deacetylase 3.
|
J Clin Invest
|
2015
|
0.75
|
97
|
Immunogenetics and transplantation.
|
Curr Opin Immunol
|
2011
|
0.75
|
98
|
Models of Lung Transplant Research: a consensus statement from the National Heart, Lung, and Blood Institute workshop.
|
JCI Insight
|
2017
|
0.75
|